Search
for
Sort by
Research 301–330 of 1000+
- Transplantation immunology: Solid organ and bone marrow
- Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart
- Effects of Intramuscular Testosterone Undecanoate on Body Composition and Bone Mineral Density in Female-to-Male Transsexuals
- Bone morphogenetic protein signaling regulates the size of hair follicles and modulates the expression of cell cycle-associated genes
- Coats' Plus: A Progressive Familial Syndrome of Bilateral Coats' Disease, Characteristic Cerebral Calcification, Leukoencephalopathy, Slow Pre- and Post-Natal Linear Growth and Defects of Bone Marrow and Integument
- Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes
- Physical Changes, Laboratory Parameters, and Bone Mineral Density During Testosterone Treatment in Adolescents with Gender Dysphoria
- Bone morphogenetic protein (BMP) signaling controls hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway
- Graft-versus-host reaction. Cutaneous manifestations following bone marrow transplantation.
- Permanent alopecia following chemotherapy and bone marrow transplantation
- A Review on Hydrogels with Photothermal Effect in Wound Healing and Bone Tissue Engineering
- Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: A possible androgenic bone protective effects induced by exemestane
- Bone Morphogenetic Protein Antagonist Noggin Promotes Skin Tumorigenesis via Stimulation of the Wnt and Shh Signaling Pathways
- Mechanical Stretch Upregulates SDF-1α in Skin Tissue and Induces Migration of Circulating Bone Marrow-Derived Stem Cells into the Expanded Skin
- Application of mesenchymal stem cells derived from bone marrow and umbilical cord in human hair multiplication
- GLI2-specific Transcriptional Activation of the Bone Morphogenetic Protein/Activin Antagonist Follistatin in Human Epidermal Cells
- The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial.
- Transplantation of bone-marrow-derived mesenchymal and epidermal stem cells contribute to wound healing with different regenerative features
- Bone density is normal in male rats treated with finasteride.
- Bone‐forming cells with pronounced spread into the third dimension in polymer scaffolds fabricated by two‐photon polymerization
- Bone morphogenetic proteins 4 and 2/7 induce osteogenic differentiation of mouse skin derived fibroblast and dermal papilla cells
- Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess
- The role of R-spondins and their receptors in bone metabolism
- Clinical and histological study of permanent alopecia after bone marrow transplantation
- A Single Injection of the Anabolic Bone Agent, Parathyroid Hormone–Collagen Binding Domain (PTH–CBD), Results in Sustained Increases in Bone Mineral Density for up to 12 Months in Normal Female Mice
- Bone vs. fat: Embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts
- Bone mineral density in hyperandrogenic amenorrhoea
- Long-term time-lapse multimodal intravital imaging of regeneration and bone-marrow-derived cell dynamics in skin
- Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroids.
- Premature Graying, Balding, and Low Bone Mineral Density in Older Women and Men